e-learning
resources
Berlin 2001
Monday 24.09.2001
Cellular immunopathology of rhinitis and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunological analysis in chronic eosinophilic pneumonia; eosinophil active cytokines and surface antigens of eosinophils
Y. Okubo, S. Takashi, A. Tsukadaira, S. I. Hayashi, M. Hayashi, K. Kubo (Matsumoto, Japan)
Source:
Annual Congress 2001 - Cellular immunopathology of rhinitis and asthma
Session:
Cellular immunopathology of rhinitis and asthma
Session type:
Thematic Poster Session
Number:
1832
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Okubo, S. Takashi, A. Tsukadaira, S. I. Hayashi, M. Hayashi, K. Kubo (Matsumoto, Japan). Immunological analysis in chronic eosinophilic pneumonia; eosinophil active cytokines and surface antigens of eosinophils. Eur Respir J 2001; 16: Suppl. 31, 1832
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Apoptotic response of eosinophils in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 190-194
Year: 2001
Inflammatory cell activation in eosinophilic and non-eosinophilic asthma
Source: Annual Congress 2006 - Immunology of the airways
Year: 2006
Eosinophilopoietins receptors, TGF-ß1 and outer-membrane integrins expression of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Bronchial hyper-responsiveness in chronic eosinophilic pneumonia is not correlated uniquely to local eosinophil infiltration
Source: Eur Respir J 2002; 20: Suppl. 38, 315s
Year: 2002
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
The eosinophil is important in asthma after all – Con
Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease
Year: 2006
Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD
Source: Eur Respir J 2016; 47:1562-1564
Year: 2016
Expression of markers of activation and chemokine receptors by bronchoalveolar lavage T-cells from subjects with asthma, eosinophilic bronchitis and normal controls
Source: Eur Respir J 2001; 18: Suppl. 33, 530s
Year: 2001
Possible role of IL-25 in eosinophilic lung inflammation in patients with eosinophilic pneumonia
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Eosinophils as potential mediators of autoimmunity in eosinophilic lung disease
Source: Eur Respir Monogr 2022; 95: 219-237
Year: 2022
Distribution of the cellular inflammatory pattern in induced sputum in an eosinophilic severe asthma population.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Serum eosinophil cationic protein as a potential biomarker for interleukin-5 antibody treatment in patients with severe uncontrolled eosinophilic asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Sputum mast cells associate with clinical and inflammatory features of asthma
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Increasing sputum basophils is a marker for eosinophil-dominant airway inflammation in adult asthma
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood
Source: Eur Respir J 2005; 26: Suppl. 49, 625s
Year: 2005
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis
Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Year: 2005
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression
Source: Eur Respir J 2003; 22: 290-297
Year: 2003
Chronic inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=126
Year: 2003
Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia
Source: Eur Respir J 2001; 17: 962-968
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept